{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7134,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de075-a527-726e-8ca0-68cd0a0bc055",
      "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558",
      "documentTitle": "Hyzon | Results Presentation Deck | 19 slides",
      "authorId": "hyzon",
      "authorName": "Hyzon",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a matrix-like structure to map strategic initiatives against time and recurrence.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/13",
      "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055",
      "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 13,
          "beatId": "b9b91bab-0935-4f54-852b-efb13013ea45",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "The Breakthrough",
          "beatSlug": "rags-to-riches-the-breakthrough",
          "evidence": "The presentation highlights Hyzon's strategic path forward (p13: Strategic Path Forward).",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a527-726e-8ca0-68cd0a0bc055",
      "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558",
      "documentTitle": "Hyzon | Results Presentation Deck | 19 slides",
      "authorId": "hyzon",
      "authorName": "Hyzon",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/14",
      "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055",
      "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 14,
          "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a527-726e-8ca0-68cd0a0bc055",
      "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558",
      "documentTitle": "Hyzon | Results Presentation Deck | 19 slides",
      "authorId": "hyzon",
      "authorName": "Hyzon",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The table includes both GAAP financial metrics and supplemental non-GAAP/operational data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/15",
      "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055",
      "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 14,
          "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a527-726e-8ca0-68cd0a0bc055",
      "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558",
      "documentTitle": "Hyzon | Results Presentation Deck | 19 slides",
      "authorId": "hyzon",
      "authorName": "Hyzon",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The data shows a significant spike in legal/consulting/accounting fees in Q2 2023 due to SEC investigation accruals.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/16",
      "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055",
      "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 14,
          "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a527-726e-8ca0-68cd0a0bc055",
      "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558",
      "documentTitle": "Hyzon | Results Presentation Deck | 19 slides",
      "authorId": "hyzon",
      "authorName": "Hyzon",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "The table includes footnotes explaining specific adjustments to the figures.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/17",
      "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055",
      "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 14,
          "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a527-726e-8ca0-68cd0a0bc055",
      "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558",
      "documentTitle": "Hyzon | Results Presentation Deck | 19 slides",
      "authorId": "hyzon",
      "authorName": "Hyzon",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/18",
      "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055",
      "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 14,
          "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a527-726e-8ca0-68cd0a0bc055",
      "docSlug": "802aae6fa40a0a18e56b9cd7c0a31558",
      "documentTitle": "Hyzon | Results Presentation Deck | 19 slides",
      "authorId": "hyzon",
      "authorName": "Hyzon",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table includes adjustments for fair value changes, stock-based compensation, and legal/regulatory matters.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a527-726e-8ca0-68cd0a0bc055/19",
      "deckHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055",
      "deckAnchorHref": "/decks/019de075-a527-726e-8ca0-68cd0a0bc055#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 19,
          "from": 14,
          "beatId": "bc4a3e5a-7ff9-48d7-8801-152b4ba24278",
          "arcName": "Rags to Riches",
          "arcSlug": "rags-to-riches",
          "beatName": "Ultimate Achievement",
          "beatSlug": "rags-to-riches-ultimate-achievement",
          "evidence": "The presentation concludes with Hyzon's Q2 financial performance, guidance, and appendix (p14: Q2 Financial Performance & Guidance, p15-19: Financials and Appendix).",
          "position": 4,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/a5WjJRMGsUX3RmUlaRbyFsLkH5cg0tFuN05gxY1jbaY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjk2Mjg2ZTA3MjgzNDU3ZTk3YjIxZGM5Y2U1OTQ2OS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/1",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/hkd0eF1LXsUTUENcxls_nV2iix8nl_j9iPVeXGOVQOU/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjk2Mjg2ZTA3MjgzNDU3ZTk3YjIxZGM5Y2U1OTQ2OS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/Jefjr9Wx7IiIecNnElpwKVLTfjBOH8VhlY_aPM7lzoY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjk2Mjg2ZTA3MjgzNDU3ZTk3YjIxZGM5Y2U1OTQ2OS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/T6reQfjSKrj81Sn7ik-QtdomMOWW55rh-GpYySRf3Jg/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8yMjk2Mjg2ZTA3MjgzNDU3ZTk3YjIxZGM5Y2U1OTQ2OS9wMDAxLnBuZw"
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/2",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide highlights two distinct pipelines: TSTx (Tissue Specific Therapeutics) and NextGen CAR-T.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/3",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "250e6c83-38a5-4886-bb70-804cf4659e47",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The presentation identifies the problem and the market opportunity.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a wave-like visual to represent market segments and their associated financial opportunities.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/4",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-4",
      "loopMatches": [
        {
          "to": 9,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92",
          "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.",
          "position": 0,
          "objective": "What are the consequences of not addressing the unmet medical needs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "250e6c83-38a5-4886-bb70-804cf4659e47",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The presentation identifies the problem and the market opportunity.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "show_traction",
      "notes": "The table uses a standard pharmaceutical pipeline format, categorizing by clinical vs preclinical status and therapy type (CAR-T vs TSTx).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/5",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-5",
      "loopMatches": [
        {
          "to": 9,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92",
          "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.",
          "position": 0,
          "objective": "What are the consequences of not addressing the unmet medical needs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "250e6c83-38a5-4886-bb70-804cf4659e47",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The presentation identifies the problem and the market opportunity.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a grouped bar chart to compare clinical outcomes across different patient segments (No BCMA, Yes BCMA, Overall).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/6",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-6",
      "loopMatches": [
        {
          "to": 9,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92",
          "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.",
          "position": 0,
          "objective": "What are the consequences of not addressing the unmet medical needs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "5027be93-535f-449a-9c55-44f893156c27",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The presentation highlights the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "Includes detailed source citations in the footer.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/7",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-7",
      "loopMatches": [
        {
          "to": 9,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92",
          "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.",
          "position": 0,
          "objective": "What are the consequences of not addressing the unmet medical needs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "5027be93-535f-449a-9c55-44f893156c27",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The presentation highlights the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes detailed source citations in the footer.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/8",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-8",
      "loopMatches": [
        {
          "to": 9,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92",
          "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.",
          "position": 0,
          "objective": "What are the consequences of not addressing the unmet medical needs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "5027be93-535f-449a-9c55-44f893156c27",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The presentation highlights the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a two-column layout to separate milestones by drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/9",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-9",
      "loopMatches": [
        {
          "to": 9,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "5f2e0111-b5c3-4127-8874-dd9c86260d92",
          "evidence": "The presentation highlights the market opportunity and the limitations of current treatments.",
          "position": 0,
          "objective": "What are the consequences of not addressing the unmet medical needs?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.7,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 9,
          "from": 6,
          "beatId": "5027be93-535f-449a-9c55-44f893156c27",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The presentation highlights the limitations of current treatments.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a side-by-side comparison of two proprietary technology platforms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/10",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-10",
      "loopMatches": [
        {
          "to": 16,
          "from": 10,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2",
          "evidence": "The presentation presents clinical results and data to support the solutions.",
          "position": 1,
          "objective": "What are the potential benefits of Immix Biopharma's solutions?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 10,
          "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "transition",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/11",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-11",
      "loopMatches": [
        {
          "to": 16,
          "from": 10,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2",
          "evidence": "The presentation presents clinical results and data to support the solutions.",
          "position": 1,
          "objective": "What are the potential benefits of Immix Biopharma's solutions?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 10,
          "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a matrix structure to compare clinical outcomes against three key value propositions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/12",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-12",
      "loopMatches": [
        {
          "to": 16,
          "from": 10,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2",
          "evidence": "The presentation presents clinical results and data to support the solutions.",
          "position": 1,
          "objective": "What are the potential benefits of Immix Biopharma's solutions?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 10,
          "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes comparative bar charts and flow cytometry data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/13",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-13",
      "loopMatches": [
        {
          "to": 16,
          "from": 10,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2",
          "evidence": "The presentation presents clinical results and data to support the solutions.",
          "position": 1,
          "objective": "What are the potential benefits of Immix Biopharma's solutions?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 10,
          "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "why_now",
      "function": "argue_timing",
      "notes": "Includes a comparison table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/14",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-14",
      "loopMatches": [
        {
          "to": 16,
          "from": 10,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2",
          "evidence": "The presentation presents clinical results and data to support the solutions.",
          "position": 1,
          "objective": "What are the potential benefits of Immix Biopharma's solutions?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 10,
          "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/15",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-15",
      "loopMatches": [
        {
          "to": 16,
          "from": 10,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2",
          "evidence": "The presentation presents clinical results and data to support the solutions.",
          "position": 1,
          "objective": "What are the potential benefits of Immix Biopharma's solutions?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 10,
          "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide compares two disease indications side-by-side with clinical metrics and competitive market context.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/16",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-16",
      "loopMatches": [
        {
          "to": 16,
          "from": 10,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "d3ed2b4b-7476-486a-bc9e-587ba67669a2",
          "evidence": "The presentation presents clinical results and data to support the solutions.",
          "position": 1,
          "objective": "What are the potential benefits of Immix Biopharma's solutions?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.7,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 16,
          "from": 10,
          "beatId": "ec348a34-4a83-4f17-b0f0-268fe2d31e3a",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The presentation presents Immix Biopharma's solutions and clinical results.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The table uses a red dashed box to highlight the key clinical data rows (ORR, CR, ICANS, CRS).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/17",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart demonstrates deepening clinical responses over time, a key indicator of therapeutic efficacy in oncology trials.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/18",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a red dashed box to highlight the key efficacy metrics for comparison.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/19",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table displays clinical trial data for NXC-201, including toxicity management metrics like Tocilizumab and Dexamethasone usage.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/20",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "peer_benchmark",
      "function": "compare_peers",
      "notes": "The slide highlights specific safety data points for two dosage groups (100x10^6 and 300x10^6 cells).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/21",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a structured table-like layout to map clinical progress against specific disease indications.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/22",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "docSlug": "2296286e07283457e97b21dc9ce59469",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 46 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-08-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The diagram illustrates a dose escalation process leading to the RP2D.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0/23",
      "deckHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0",
      "deckAnchorHref": "/decks/019de075-a5cb-73ea-a4ef-8f4a27a8a7b0#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}